Trial Profile
Joint Application of Human Insulin and Rapid Insulin Analogue in Control of Postprandial Glycemia.
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Insulin (Primary) ; Insulin aspart (Primary)
- Indications Type 1 diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
- Acronyms CPIT
- 20 Mar 2010 New trial record